Endo International plc Quarterly Cost of Revenue in USD from Q1 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Endo International plc quarterly/annual Cost of Revenue history and growth rate from Q1 2013 to Q4 2023.
  • Endo International plc Cost of Revenue for the quarter ending December 31, 2023 was $250M, a 15.2% decline year-over-year.
  • Endo International plc Cost of Revenue for the twelve months ending December 31, 2023 was $946M, a 13.4% decline year-over-year.
  • Endo International plc annual Cost of Revenue for 2023 was $946M, a 13.4% decline from 2022.
  • Endo International plc annual Cost of Revenue for 2022 was $1.09B, a 10.5% decline from 2021.
  • Endo International plc annual Cost of Revenue for 2021 was $1.22B, a 15.4% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $946M $250M -$44.7M -15.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 $991M $230M -$30.9M -11.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $1.02B $234M -$29.9M -11.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $1.05B $233M -$40.5M -14.8% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $1.09B $294M -$17M -5.45% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 $1.11B $261M -$24.8M -8.68% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $1.13B $264M -$54.7M -17.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $1.19B $273M -$32.1M -10.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $1.22B $311M -$58.3M -15.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-06
Q3 2021 $1.28B $286M -$62M -17.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $1.34B $318M -$17.6M -5.24% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $1.36B $305M -$83.5M -21.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $1.44B $370M -$30.5M -7.63% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 $1.47B $348M -$41.1M -10.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $1.51B $336M -$52.1M -13.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $1.57B $389M -$3.11M -0.79% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $1.57B $400M -$33.2M -7.65% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $1.6B $389M -$23.8M -5.76% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $1.63B $388M +$6.3M +1.65% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $1.62B $392M -$11.7M -2.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $1.63B $433M -$72.4M -14.3% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $1.7B $413M -$102M -19.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-04
Q2 2018 $1.81B $382M -$157M -29.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $1.96B $404M -$265M -39.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $2.23B $506M -$251M -33.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 $2.48B $515M -$43M -7.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $2.52B $539M -$92.8M -14.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $2.62B $669M -$19.7M -2.87% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $2.63B $757M -$53.5M -6.6% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $2.69B $557M +$115M +26% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $2.57B $632M +$193M +44.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $2.38B $689M +$304M +79.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $2.08B $810M +$436M +116% Oct 1, 2015 Dec 31, 2015 8-K 2018-05-08
Q3 2015 $1.64B $442M +$101M +29.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $1.54B $439M +$135M +44.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $1.4B $384M +$172M +80.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $1.23B $374M +$273M +271% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $958M $341M +$83.4M +32.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $875M $303M +$30M +11% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $845M $213M -$41.7M -16.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $887M $101M Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $258M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $273M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 $254M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.